ストックスクリーナーアプリを入手
193.44
5.18%
9.5799
Astrazeneca Plc (AZN) 最新ニュース
China's CSPC Pharmaceutical Group to partner with AstraZeneca for renal disease drug - marketscreener.com
Abbisko Therapeutics Partners with AstraZeneca on Lung Cancer Th - GuruFocus
Abbisko teams with AstraZeneca on lung cancer trial after China IND clearance - Stock Titan
Why Astrazeneca (AZN) Dipped More Than Broader Market Today - Yahoo Finance
AstraZeneca PLC (AZN) Shares Fall 3.0% -- What GF Score of 76 Te - GuruFocus
AstraZeneca PLC Stock (AZN) Moved Down by 3.02% on Jul 1: What Investors Need To Know - TradingKey
AstraZeneca plc focuses on long-term growth as global pipeline expands - AD HOC NEWS
AstraZeneca admits 14,784 shares to London Stock Exchange - Investing.com
AstraZeneca PLC outlines long-term growth strategy as global drug portfolio expands - AD HOC NEWS
AstraZeneca admits 14,784 shares to London Stock Exchange By Investing.com - Investing.com Canada
AstraZeneca (NYSE: AZN) adds 14,784 employee scheme shares - Stock Titan
AstraZeneca (AZN) reports 1.55B total voting rights as of June 2026 - Stock Titan
REGAstraZeneca PLCAdmission of Further Securities to Trading - TradingView
AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors (Revised) - TradingView
ASTRAZENECA : Goldman Sachs reaffirms its Buy rating - marketscreener.com
BofA Forecasts In-line Q2 Sales, EPS for AstraZeneca; Buy Rating Maintained - marketscreener.com
Price to earnings forward of AstraZeneca PLC – SWB:ZEG - TradingView
ETFs Investing in AstraZeneca PLC Stocks - TradingView
AstraZeneca slides Tuesday, underperforms market - MarketWatch
AstraZenecaEnhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours - marketscreener.com
AstraZeneca PLC strengthened by Enhertu EU approval. JP Morgan reiterates buy rating on the stock - AD HOC NEWS
ASTRAZENECA : Sell rating from Deutsche Bank - marketscreener.com
RB Capital Management, LLC's AstraZeneca PLC(AZN) Holding History - GuruFocus
ASTRAZENECA : Receives a Buy rating from JP Morgan - marketscreener.com
AstraZeneca To Pay $34M In Texas Kickbacks Settlement - Law360
AstraZeneca Details Bone Health Data For Strensiq Successor - insights.citeline.com
AstraZeneca Advances Rare Bone Disease Pipeline While Enhertu Expands In Europe - Benzinga
Astrazeneca plc Datroway Recommends for Approval in EU for TNBC - marketscreener.com
AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors - TradingView
EU clears AstraZeneca (AZN) and Daiichi Sankyo’s Enhertu for HER2+ solid tumours - Stock Titan
AstraZeneca, Daiichi Sankyo Win EU Approval for Enhertu in HER2-positive Solid Tumors - marketscreener.com
AstraZeneca's Datroway and Enhertu candidates receive EU approval - Sharecast.com
AstraZeneca and Daiichi Sankyo’s Datroway recommended for EU approval in metastatic TNBC - DirectorsTalk Interviews
Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours - AstraZeneca
AstraZeneca’s Datroway gets EU panel backing for breast cancer By Investing.com - Investing.com UK
AZN Stock Quote Price and Forecast - CNN
Price to sales forward of AstraZeneca PLC – LSE:AZN - TradingView
AstraZeneca PLC AZN Q3 2025 Earnings Call Dallas Cowboys Schedule 2026 (4z9l16BTZU) - Mshale
Price to sales forward of AstraZeneca PLC ADR – BCBA:AZN.CI - TradingView
AstraZeneca highlights long-term oncology pipeline, shares supported by solid S&P 500 presence - Ad-hoc-news.de
AstraZeneca focuses on long-term oncology strategy, shares anchored in the FTSE 100 - Ad-hoc-news.de
The Breztri Aerosphere from AstraZeneca plctriple therapy aims at severe COPD - Ad-hoc-news.de
AstraZeneca cautious after EU panel vote, shares reflect Tavneos setback - Ad-hoc-news.de
AstraZeneca climbs Friday, outperforms market - MarketWatch
Why Did AstraZeneca (AZN) Stock Dip More Than the Market Today - Kavout | AI
Could This Clinical Milestone Reshape AstraZeneca’s (LSE:AZN) Future? - Kalkine Media
Daiichi Sankyo and AstraZeneca Announce Datroway Recommends for Approval in EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy - marketscreener.com
Jefferies names AstraZeneca a top pick ahead of pivotal heart drug readout - Yahoo Finance
AstraZeneca updates on pipeline and AI efforts, shares tracked by analysts - Ad-hoc-news.de
AstraZeneca's, Daiichi's Datroway recommended for further EU approval - London South East
AstraZeneca : Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy - marketscreener.com
Could AstraZeneca (LSE:AZN) Continue Leading the Healthcare Space? - Kalkine Media
Astrazeneca (AZN) Stock Price, News & Analysis $AZN - MarketBeat
Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy - AstraZeneca
ASTRAZENECA : Gets a Buy rating from Jefferies - marketscreener.com
AstraZeneca PLC Actuals & Estimates (LSE:AZN) - TradingView
AstraZeneca PLC ADR Unsponsored Brazilian Depositary Receipt Repr 0.1666 ADR - TradingView
Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note - sharewise.com
AstraZeneca PLC Actuals & Estimates (NYSE:AZN) - TradingView
AstraZeneca outlines next growth phase, shares sit on solid large-cap footing - Ad-hoc-news.de
Enterprise value to revenue forward of AstraZeneca PLC – LSE:AZN - TradingView
Enterprise value to EBIT forward of AstraZeneca PLC – LSE:AZN - TradingView
Enterprise value to EBITDA forward of AstraZeneca PLC – LSE:AZN - TradingView
Enterprise value to EBIT forward of AstraZeneca PLC ADR – BCBA:AZN.CI - TradingView
Price to earnings forward of AstraZeneca PLC ADR – BCBA:AZN.CI - TradingView
AstraZeneca reports positive Tagrisso data, shares stay in focus on NASDAQ - Ad-hoc-news.de
Enterprise value to revenue forward of AstraZeneca PLC ADR – BCBA:AZN.CI - TradingView
AstraZeneca PLC (AZN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why is AstraZeneca (LSE:AZN) holding the spotlight as UK pharma stays firm today? - Kalkine Media
Can AstraZeneca PLC (AZN) Grow Its Rare Disease Portfolio Through Ultomiris Expansion? - Yahoo Finance
AstraZeneca and YMCA target cancer screening gaps in 75 communities - Stock Titan
AstraZeneca’s Next Chapter: What Is Driving Market Attention? - Kalkine Media
AstraZeneca operations and pipeline, shares anchored in FTSE 100 - Ad-hoc-news.de
2.91%
大文字化:
|
ボリューム (24 時間):